Chuanli Ren, Chongxu Han Abstract China accounts for nearly half of the incidence and mortality of lung cancer in the world. Furthermore, trends in lung cancer in China are increasing younger in age and the situation is deteriorating. As a whole although screening for early lung cancer may cause a small fraction of overdiagnosis and anxiety of […]
© 2021 BioMark Diagnostics Inc. All Rights Reserved. BioMark’s mission is to provide universal access to a new paradigm in cancer diagnostics using metabolomics.